Cardiolife’s AI-powered ECG interpretation software has received regulatory approval for commercial use in the United Arab Emirates, enabling the company to bring its technology to healthcare providers across the UAE and marking another important step in its international expansion.

Cardiolife is a consortium partner in a Portuguese–EU research program under the COMPETE 2030 initiative, focused on developing advanced digital health solutions for cardiovascular care. The project has been granted EU funding and is currently well underway.

Cardiolife’s AI-powered ECG interpretation software has been included in the Australian Register of Therapeutic Goods (ARTG No. 524682), enabling the company to supply its technology in Australia and marking another step in its international growth.

We are proud to share that Cardiolife has been selected to join the June 2026 Mayo Clinic Platform_Accelerate cohort.

Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide.

Cardiolife is pleased to announce the appointment of Trygve Refvem to its Board of Directors. This further strengthens Cardiolife’s board and strategic capabilities as the company continues to scale internationally.

Cardiolife is pleased to announce that Annie Campbell has joined the company as Head of Communications. She will lead Cardiolife’s global communication efforts, supporting the company’s continued growth and positioning in AI-driven cardiac diagnostics.

Cardiolife is pleased to announce the appointment of Rui Assunção as Vice President of Sales, as part of strengthening the company’s commercial organization and accelerating global growth.

Cardioline, a global ECG manufacturer with more than 60 years of heritage, and Cardiolife, a leading provider of high-precision AI-powered ECG interpretation software, announce a strategic partnership.

Cardiolife is pleased to announce the appointment of Dr. Sergio Ramalho as the company’s new Chief Medical Officer (CMO), strengthening Cardiolife’s clinical leadership as it advances its medical strategy and global product development.

Cardiolife is strengthening its regulatory and quality leadership with the appointment of Luísa Silva as the company’s new Quality Assurance and Regulatory Affairs (QARA) Manager. In addition to this role, Luísa will also serve as Person Responsible for Regulatory Compliance (PRRC).

Cardiolife is pleased to announce that its AI-powered cardiac diagnostic software is now registered for commercial use in Brazil by Agência Nacional de Vigilância Sanitária (ANVISA)

Cardiolife is pleased to announce the appointment of João Pedro Leite as its new Chief Operating Officer (COO). João Pedro Leite brings over 20 years of experience in technology and operational management, with a proven track record in business process improvement and growth strategies within the software industry.

Cardiolife, a pioneering developer of AI-driven ECG interpretation software, is delighted to announce the appointment of Mike Ferguson as its new Chief Commercial Officer (CCO).

Vishwa Parimi has been appointed Head of Sales Europe at  Cardiolife and will lead  the commercial strategy across the region, with a focus on growth, strategic partnerships, and delivering exceptional value to customers.

Digital Logic Kardio Software SA has successfully secured CE certification under the EU Medical Device Regulation (MDR) for Cardiolife, its AI-driven ECG analysis software.

Cardiolife is pleased to announce the appointment of Dr. João Primo as Head of Medical, further strengthening its commitment to developing AI-powered medical software for ECG interpretation, enhancing cardiac care and improving clinical workflow.

André Fazenda joins Cardiolife as QARA (Quality Assurance & Regulatory Affairs) Manager, bringing extensive experience in medical device certification, regulatory compliance, and quality management.

Cardiolife has successfully obtained ISO 13485:2016 certification for its Quality Management System (QMS)